{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:18Z","timestamp":1792176018274,"version":"4.4.0"},"reference-count":41,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1248\/bpb.b19-00050","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T22:03:07Z","timestamp":1558994587000},"page":"1310-1321","source":"Crossref","is-referenced-by-count":50,"title":["Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes &lt;i&gt;via&lt;\/i&gt; PI3K\/AKT\/GSK3\u03b2 Signaling Pathway"],"prefix":"10.1248","volume":"42","author":[{"given":"Qifei","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chang","sequence":"additional","affiliation":[{"name":"Key Disciplines of State Administration of TCM for Collateral Disease, Affiliated Yiling Hospital of Hebei Medical University"},{"name":"National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Hebei Yiling Pharmaceutical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wei","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Hebei Yiling Pharmaceutical Research Institute"},{"name":"Key Laboratory of State Administration of TCM (Cardio-Cerebral Vessel Collateral Disease)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Yin","sequence":"additional","affiliation":[{"name":"Key Disciplines of State Administration of TCM for Collateral Disease, Affiliated Yiling Hospital of Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Bei","sequence":"additional","affiliation":[{"name":"Key Disciplines of State Administration of TCM for Collateral Disease, Affiliated Yiling Hospital of Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Wang","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Hebei Yiling Pharmaceutical Research Institute"},{"name":"Key Laboratory of State Administration of TCM (Cardio-Cerebral Vessel Collateral Disease)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Liang","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Hebei Yiling Pharmaceutical Research Institute"},{"name":"Key Laboratory of Hebei Province for Collateral Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Hebei Medical University"},{"name":"Key Disciplines of State Administration of TCM for Collateral Disease, Affiliated Yiling Hospital of Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Leoni G, Soehnlein O. (Re)solving repair after myocardial infarction. <i>Front Pharmacol.<\/i>, <b>9<\/b>, 1342 (2018).","DOI":"10.3389\/fphar.2018.01342"},{"key":"2","unstructured":"2) Ayoub KF, Pothineni NVK, Rutland J, Ding Z, Mehta JL. Immunity, inflammation, and oxidative stress in heart failure: emerging molecular targets. <i>Cardiovasc. Drugs Ther.<\/i>, <b>31<\/b>, 593\u2013608 (2017)."},{"key":"3","unstructured":"3) Hou L, Guo J, Xu F, Weng X, Yue W, Ge J. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis. <i>Basic Res. Cardiol.<\/i>, <b>113<\/b>, 28 (2018)."},{"key":"4","unstructured":"4) van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. <i>Eur. J. Heart Fail.<\/i>, <b>21<\/b>, 425\u2013435 (2019)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Torrealba N, Aranguiz P, Alonso C, Rothermel BA, Lavandero S. Mitochondria in structural and functional cardiac remodeling. <i>Adv. Exp. Med. Biol.<\/i>, <b>982<\/b>, 277\u2013306 (2017).","DOI":"10.1007\/978-3-319-55330-6_15"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. <i>Circ. Res.<\/i>, <b>122<\/b>, 1460\u20131478 (2018).","DOI":"10.1161\/CIRCRESAHA.118.310082"},{"key":"7","unstructured":"7) M\u00fcnzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-part series. <i>J. Am. Coll. Cardiol.<\/i>, <b>70<\/b>, 212\u2013229 (2017)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Park ES, Kang DH, Kang JC, Jang YC, Lee MJ, Chung HJ, Yi KY, Kim DE, Kim B, Shin HS. Cardioprotective effect of KR-33889, a novel PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cells and isolated rat hearts. <i>Arch. Pharm. Res.<\/i>, <b>40<\/b>, 640\u2013654 (2017).","DOI":"10.1007\/s12272-017-0912-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Liao YX, Zhang ZP, Zhao J, Liu JP. Effects of fibronectin 1 on cell proliferation, senescence and apoptosis of human glioma cells through the PI3K\/AKT signaling pathway. <i>Cell. Physiol. Biochem.<\/i>, <b>48<\/b>, 1382\u20131396 (2018).","DOI":"10.1159\/000492096"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Xu L, Jiang X, Wei F, Zhu H. Leonurine protects cardiac function following acute myocardial infarction through antiapoptosis by the PI3K\/AKT\/GSK3beta signaling pathway. <i>Mol. Med. Rep.<\/i>, <b>18<\/b>, 1582\u20131590 (2018).","DOI":"10.3892\/mmr.2018.9084"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wu JH, Zhang SH, Gao FJ, Lei Y, Chen XY, Gao F, Zhang SJ, Sun XH. RNAi screening identifies GSK3beta as a regulator of DRP1 and the neuroprotection of lithium chloride against elevated pressure involved in downregulation of DRP1. <i>Neurosci. Lett.<\/i>, <b>554<\/b>, 99\u2013104 (2013).","DOI":"10.1016\/j.neulet.2013.08.057"},{"key":"12","unstructured":"12) Lv D, Bai Z, Yang L, Li X, Chen X. Lipid emulsion reverses bupivacaine-induced apoptosis of h9c2 cardiomyocytes: PI3K\/Akt\/GSK-3\u03b2 signaling pathway. <i>Environ. Toxicol. Pharmacol.<\/i>, <b>42<\/b>, 85\u201391 (2016)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zhang J, Wei C, Wang H, Tang S, Jia Z, Wang L, Xu D, Wu Y. Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2013<\/b>, 378298 (2013).","DOI":"10.1155\/2013\/378298"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Li X, Zhang J, Huang J, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R, Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. <i>J. Am. Coll. Cardiol.<\/i>, <b>62<\/b>, 1065\u20131072 (2013).","DOI":"10.1016\/j.jacc.2013.05.035"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Han A, Lu Y, Zheng Q, Zhang J, Zhao Y, Zhao M, Cui X. Qiliqiangxin attenuates cardiac remodeling <i>via<\/i> inhibition of TGF-\u03b21\/Smad3 and NF-\u03baB signaling pathways in a rat model of myocardial infarction. <i>Cell. Physiol. Biochem.<\/i>, <b>45<\/b>, 1797\u20131806 (2018).","DOI":"10.1159\/000487871"},{"key":"16","unstructured":"16) Wang J, Zhou J, Ding X, Zhu L, Jiang K, Fu M, Wang S, Hu K, Ge J. <i>Qiliqiangxin<\/i> improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction. <i>Int. J. Clin. Exp. Pathol.<\/i>, <b>8<\/b>, 6596\u20136606 (2015)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang J, Zhou J, Wang Y, Yang C, Fu M, Zhang J, Han X, Li Z, Hu K, Ge J. Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells <i>via<\/i> NRG-1\/ErbB-PI3K\/Akt\/mTOR pathway. <i>J. Cell. Mol. Med.<\/i>, <b>21<\/b>, 1905\u20131914 (2017).","DOI":"10.1111\/jcmm.13111"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zhang Y, Li C, Meng H, Guo D, Zhang Q, Lu W, Wang Q, Wang Y, Tu P. BYD ameliorates oxidative stress-induced myocardial apoptosis in heart failure post-acute myocardial infarction <i>via<\/i> the P38 MAPK-CRYAB signaling pathway. <i>Front Physiol.<\/i>, <b>9<\/b>, 505 (2018).","DOI":"10.3389\/fphys.2018.00505"},{"key":"19","unstructured":"19) Liang T, Zhang Y, Yin S, Gan T, An T, Zhang R, Wang Y, Huang Y, Zhou Q, Zhang J. Cardio-protect effect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction. <i>Am. J. Transl. Res.<\/i>, <b>8<\/b>, 2047\u20132058 (2016)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tao L, Shen S, Fu S, Fang H, Wang X, Das S, Sluijter JP, Rosenzweig A, Zhou Y, Kong X, Xiao J, Li X. Traditional Chinese medication qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. <i>Sci. Rep.<\/i>, <b>5<\/b>, 8374 (2015).","DOI":"10.1038\/srep08374"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shen S, Jiang H, Bei Y, Zhang J, Zhang H, Zhu H, Zhang C, Yao W, Wei C, Shang H, Li X. Qiliqiangxin attenuates adverse cardiac remodeling after myocardial infarction in ovariectomized mice <i>via<\/i> activation of PPAR\u03b3. <i>Cell. Physiol. Biochem.<\/i>, <b>42<\/b>, 876\u2013888 (2017).","DOI":"10.1159\/000478641"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zhang L, Liu Y, Li JY, Li LZ, Zhang YL, Gong HY, Cui Y. Protective effect of rosamultin against H<sub>2<\/sub>O<sub>2<\/sub>-induced oxidative stress and apoptosis in H9c2 cardiomyocytes. <i>Oxid. Med. Cell. Longev.<\/i>, <b>2018<\/b>, 8415610 (2018).","DOI":"10.1155\/2018\/8415610"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sundaram R L, Sali VK, Vasanthi HR. Protective effect of rutin isolated from <i>Spermococe hispida<\/i> against cobalt chloride-induced hypoxic injury in H9c2 cells by inhibiting oxidative stress and inducing apoptosis. <i>Phytomedicine<\/i>, <b>51<\/b>, 196\u2013204 (2018).","DOI":"10.1016\/j.phymed.2018.09.229"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yu D, Li M, Tian Y, Liu J, Shang J. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia\/reperfusion injury. <i>Life Sci.<\/i>, <b>122<\/b>, 15\u201325 (2015).","DOI":"10.1016\/j.lfs.2014.11.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Zhu J, Ye Q, Xu S, Chang YX, Liu X, Ma Y, Zhu Y, Hua S. Shengmai injection alleviates H<sub>2<\/sub>O<sub>2<\/sub> induced oxidative stress through activation of AKT and inhibition of ERK pathways in neonatal rat cardiomyocytes. <i>J. Ethnopharmacol.<\/i>, <b>239<\/b>, 111677 (2019).","DOI":"10.1016\/j.jep.2019.01.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chi J, Li Z, Hong X, Zhao T, Bie Y, Zhang W, Yang J, Feng Z, Yu Z, Xu Q, Zhao L, Liu W, Gao Y, Yang H, Yang J, Liu J, Yang W. Inhalation of hydrogen attenuates progression of chronic heart failure <i>via<\/i> suppression of oxidative stress and P53 related to apoptosis pathway in rats. <i>Front Physiol.<\/i>, <b>9<\/b>, 1026 (2018).","DOI":"10.3389\/fphys.2018.01026"},{"key":"27","unstructured":"27) Kumar P, Bhadauria AS, Singh AK, Saha S. Betulinic acid as apoptosis activator: molecular mechanisms, mathematical modeling and chemical modifications. <i>Life Sci.<\/i>, <b>209<\/b>, 24\u201333 (2018)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Teringova E, Tousek P. Apoptosis in ischemic heart disease. <i>J. Transl. Med.<\/i>, <b>15<\/b>, 87 (2017).","DOI":"10.1186\/s12967-017-1191-y"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nagoor MMF, Laham F, Azimullah S, Tariq S, Ojha S. \u03b1-Bisabolol abrogates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and intrinsic pathway of apoptosis in rats. <i>Mol. Cell. Biochem.<\/i>, <b>453<\/b>, 89\u2013102 (2019).","DOI":"10.1007\/s11010-018-3434-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Park ES, Kang JC, Jang YC, Park JS, Jang SY, Kim DE, Kim B, Shin HS. Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under H<sub>2<\/sub>O<sub>2<\/sub>-induced apoptosis. <i>J. Ethnopharmacol.<\/i>, <b>153<\/b>, 552\u2013560 (2014).","DOI":"10.1016\/j.jep.2014.02.019"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Koundouros N, Poulogiannis G. Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer. <i>Front Oncol.<\/i>, <b>8<\/b>, 160 (2018).","DOI":"10.3389\/fonc.2018.00160"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chen R, Sun G, Yang L, Wang J, Sun X. Salvianolic acid B protects against doxorubicin induced cardiac dysfunction <i>via<\/i> inhibition of ER stress mediated cardiomyocyte apoptosis. <i>Toxicol. Res.<\/i>, <b>5<\/b>, 1335\u20131345 (2016).","DOI":"10.1039\/C6TX00111D"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ma L, Li XP, Ji HS, Liu YF, Li EZ. Baicalein protects rats with diabetic cardiomyopathy against oxidative stress and inflammation injury <i>via<\/i> phosphatidylinositol 3-kinase (PI3K)\/AKT pathway. <i>Med. Sci. Monit.<\/i>, <b>24<\/b>, 5368\u20135375 (2018).","DOI":"10.12659\/MSM.911455"},{"key":"34","unstructured":"34) Kuzmicic J, Del CA, Lopez-Crisosto C, Morales PE, Pennanen C, Bravo-Sagua R, Hechenleitner J, Zepeda R, Castro PF, Verdejo HE, Parra V, Chiong M, Lavandero S. Mitochondrial dynamics: a potential new therapeutic target for heart failure. <i>Rev. Esp. Cardiol.<\/i>, <b>64<\/b>, 916\u2013923 (2011)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Estaquier J, Arnoult D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome <i>c<\/i> during apoptosis. <i>Cell Death Differ.<\/i>, <b>14<\/b>, 1086\u20131094 (2007).","DOI":"10.1038\/sj.cdd.4402107"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Tanaka A, Youle RJ. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. <i>Mol. Cell<\/i>, <b>29<\/b>, 409\u2013410 (2008).","DOI":"10.1016\/j.molcel.2008.02.005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Chang CR, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. <i>J. Biol. Chem.<\/i>, <b>282<\/b>, 21583\u201321587 (2007).","DOI":"10.1074\/jbc.C700083200"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Xu T, Ding W, Ao X, Chu X, Wan Q, Wang Y, Xiao D, Yu W, Li M, Yu F, Wang J. ARC regulates programmed necrosis and myocardial ischemia\/reperfusion injury through the inhibition of mPTP opening. <i>Redox Biol.<\/i>, <b>20<\/b>, 414\u2013426 (2019).","DOI":"10.1016\/j.redox.2018.10.023"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Song YH, Cai H, Zhao ZM, Chang WJ, Gu N, Cao SP, Wu ML. Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation. <i>Biomed. Pharmacother.<\/i>, <b>83<\/b>, 1089\u20131094 (2016).","DOI":"10.1016\/j.biopha.2016.08.016"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Zhu M, Li J, Wang K, Hao X, Ge R, Li Q. Isoquercitrin inhibits hydrogen peroxide-induced apoptosis of EA.hy926 cells <i>via<\/i> the PI3K\/Akt\/GSK3\u03b2 signaling pathway. <i>Molecules<\/i>, <b>21<\/b>, 356 (2016).","DOI":"10.3390\/molecules21030356"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Li Y, Ruan X, Chen T, Gao J, Wang X. Anti-apoptotic effect of Suxiao Jiuxin Pills against hypoxia-induced injury through PI3K\/Akt\/GSK3\u03b2 pathway in HL-1 cardiomyocytes. <i>J. Chin. Med. Assoc.<\/i>, <b>81<\/b>, 816\u2013824 (2018).","DOI":"10.1016\/j.jcma.2018.02.002"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/8\/42_b19-00050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T03:22:07Z","timestamp":1564802527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/8\/42_b19-00050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00050","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}